Primary care physicians&#39; perspectives on managing mild-to-moderate COVID-19 in populations at risk for progression to severe disease: a survey-based study.

Paxlovid (nirmatrelvir/ritonavir) - Pfizer

http://www.ncbi.nlm.nih.gov/pubmed/42163133

Avital Bareket-Samish; Carmel Kasher; Shirley Shapiro Ben David; Tal Distelman-Menachem

May 22, 2026